Briefing: The financial sector is sending some spooky technical signals about the stock market
Strategic angle: MarketWatch reports on unsettling indicators from the financial sector regarding stock market trends.
Strategic angle: MarketWatch reports on unsettling indicators from the financial sector regarding stock market trends.
Strategic angle: Berkshire Hathaway filed its definitive proxy statement with the SEC ahead of the company's annual shareholders meeting.
Strategic angle: Analyzing the potential decline of Opendoor Technologies stock.
Strategic angle: Large U.S. firms spent about $1 trillion on their own shares in 2025, according to Morningstar estimates.
Strategic angle: MarketWatch explores the potential impacts of private-credit issues on investment portfolios.
Strategic angle: A deep dive into the economic implications of rising inflation in the Hormuz region.
Strategic angle: MarketWatch reports on the growing panic in the stock market and anticipates increased selling activity.
Strategic angle: S&P Global reports on the positive impact of rising lithium prices on industry margins and the potential for unconventional supply sources.
Strategic angle: MarketWatch reports on the potential for a prolonged downturn in major stock indices.
Strategic angle: Mortgage rates jumped to a seven-month high Friday as war in Iran pushed bond yields higher.
Strategic angle: The Supreme Court's ruling on Trump's tariffs could lead to significant refunds, suggesting companies should pass this benefit to workers.
Strategic angle: RBC Capital has increased its price target for Kinetik Holdings, signaling confidence in the company's future performance.
Strategic angle: Mizuho has increased the price target for NETSTREIT (NTST) stock.
Strategic angle: For JPMorgan Chase, winning the niche of startup banking from rivals is about more than just gaining deposits: It's a bet to future-proof the largest U.S. bank.
Strategic angle: The PCE price index for January was expected to show headline inflation at 2.9% and core at 3.1%.
Strategic angle: A significant investment in a biotech stock following a major clinical success.
Strategic angle: Arista's stock remains stable as positive forecasts emerge.
Strategic angle: Congressional Democrats warn new tariffs could raise household costs as the administration moves to replace revenue lost after a Supreme Court ruling.
Strategic angle: China's Foreign Ministry criticized the Trump administration's trade investigation as a "pretext" for tariffs while advancing its own economic strategy.
Strategic angle: Explore top mining stocks recommended for investment in March 2026.